Foghorn Therapeutics Inc. financial data

Symbol
FHTX on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
11 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 264% % -41%
Debt-to-equity -364% % 50%
Return On Equity 88% % -53%
Return On Assets -33% % -14%
Operating Margin -279% % 38%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 58,700,246 shares 5.6%
Common Stock, Shares, Outstanding 56,657,329 shares 1.9%
Entity Public Float $172,300,000 USD -16%
Common Stock, Value, Issued $6,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 62,980,959 shares 15%
Weighted Average Number of Shares Outstanding, Diluted 62,980,959 shares 15%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $30,909,000 USD 37%
Research and Development Expense $85,466,000 USD -9.6%
General and Administrative Expense $27,550,000 USD -2.9%
Operating Income (Loss) $86,389,000 USD 16%
Nonoperating Income (Expense) $12,106,000 USD -25%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $86,620,000 USD 8%
Income Tax Expense (Benefit) $0 USD -100%
Net Income (Loss) Attributable to Parent $74,283,000 USD 14%
Earnings Per Share, Basic -1.18 USD/shares 25%
Earnings Per Share, Diluted -1.18 USD/shares 25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $80,876,000 USD 46%
Assets, Current $163,235,000 USD -35%
Operating Lease, Right-of-Use Asset $30,949,000 USD 37%
Other Assets, Noncurrent $4,000 USD -94%
Assets $198,103,000 USD -30%
Accounts Payable, Current $4,266,000 USD 13%
Employee-related Liabilities, Current $5,921,000 USD 25%
Accrued Liabilities, Current $11,357,000 USD 33%
Contract with Customer, Liability, Current $43,192,000 USD -5.3%
Liabilities, Current $59,738,000 USD -11%
Contract with Customer, Liability, Noncurrent $205,962,000 USD -12%
Operating Lease, Liability, Noncurrent $40,347,000 USD 44%
Other Liabilities, Noncurrent $556,000 USD
Liabilities $306,603,000 USD -7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $24,000 USD -82%
Retained Earnings (Accumulated Deficit) $632,467,000 USD -13%
Stockholders' Equity Attributable to Parent $108,500,000 USD -138%
Liabilities and Equity $198,103,000 USD -30%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $23,968,000 USD 18%
Net Cash Provided by (Used in) Financing Activities $139,000 USD -88%
Net Cash Provided by (Used in) Investing Activities $29,401,000 USD 8.5%
Common Stock, Shares Authorized 175,000,000 shares 0%
Common Stock, Shares, Issued 56,657,329 shares 1.9%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,083,000 USD 31%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $84,126,000 USD 47%
Deferred Tax Assets, Valuation Allowance $187,635,000 USD 13%
Deferred Tax Assets, Gross $196,560,000 USD 13%
Operating Lease, Liability $41,270,000 USD 11%
Payments to Acquire Property, Plant, and Equipment $28,000 USD -72%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $74,394,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid $60,811,000 USD 48%
Operating Lease, Liability, Current $923,000 USD -90%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,280,000 USD -60%
Lessee, Operating Lease, Liability, to be Paid, Year One $979,000 USD -91%
Operating Lease, Weighted Average Discount Rate, Percent 0.0724 pure 37%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $19,177,000 USD 385%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,713,000 USD -48%
Deferred Tax Assets, Operating Loss Carryforwards $55,169,000 USD 280%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,774,000 USD -20%
Additional Paid in Capital $523,937,000 USD 2.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $3,332,000 USD 6.8%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%